- Open Access
Localization and phosphorylation of Plasmodium falciparum nicotinamide/nicotinate mononucleotide adenylyltransferase (PfNMNAT) in intraerythrocytic stages
© The Author(s) 2018
- Received: 6 June 2017
- Accepted: 4 April 2018
- Published: 11 April 2018
Nicotinamide adenine dinucleotide (NAD+) is an essential molecule in the energy metabolism of living beings, and it has various cellular functions. The main enzyme in the biosynthesis of this nucleotide is nicotinamide/nicotinate mononucleotide adenylyltransferase (NMNAT, EC 184.108.40.206/18) because it is the convergence point for all known biosynthetic pathways. NMNATs have divergences in both the number of isoforms detected and their distribution, depending on the organism.
In the laboratory of basic research in biochemistry (LIBBIQ: acronym in Spanish) the NMNATs of protozoan parasites (Leishmania braziliensis, Plasmodium falciparum, Trypanosoma cruzi, and Giardia duodenalis) have been studied, analysing their catalytic properties through the use of proteins. Recombinants and their cellular distribution essentially. In 2014, O’Hara et al. determined the cytoplasmic localization of NMNAT of P. falciparum, using a transgene coupled to GFP, however, the addition of labels to the study protein can modify several of its characteristics, including its sub-cellular localization.
This study confirms the cytoplasmic localization of this protein in the parasite through recognition of the endogenous protein in the different stages of the asexual life cycle. Additionally, the study found that PfNMNAT could be a phosphorylation target at serine, tyrosine and threonine residues, and it shows variations during the asexual life cycle.
These experiments confirmed that the parasite is situated in the cytoplasm, fulfilling the required functions of NAD+ in this compartment, the PfNMNAT is regulated in post-transcription processes, and can be regulated by phosphorylation in its residues.
- Plasmodium falciparum
- NAD+ metabolism
Plasmodium falciparum causes malaria and is the leading parasitic cause of death worldwide . Given that, to date, there is no clinically available vaccine and considering the recent increase in drug-resistant parasite strains, it is necessary to find proteins that serve as therapeutic targets for control of the disease .
During its asexual life cycle, the parasite infects erythrocytes, increasing oxidative stress intracellular after haemoglobin degradation. For this reason, the parasite has a variety of antioxidant systems that depend directly on the reducing power of the cellular content of NADPH. In addition to infecting the erythrocyte, P. falciparum increases the activity of the pentose phosphate cycle, NAD+ synthesis, and the expression of glycolytic enzymes in order to adapt to the intracellular environment [3, 4]. Therefore, the role of NAD(P)+ is essential since it is a key factor in some essential biological and biochemical processes of the parasite . That is why the identification and characterization of the enzymes involved in its biosynthesis prove interesting. One of the most important enzymes in this pathway is the nicotinamide/nicotinate mononucleotide adenylyltransferase (NMNAT; EC:220.127.116.11) as it is the point of convergence of the two NAD+ biosynthetic pathways, de novo and salvage . NMNAT has been identified in organisms as diverse as archaea, bacteria and eukaryotes [7, 8]. In humans, three isoforms (NMNATs 1, 2 and 3) have been identified in the nucleus, Golgi apparatus and mitochondria, respectively [9, 10]. Each of them has specific sequences that allow its intracellular localization.
Plasmodium falciparum NMNAT has already been identified [11, 12], and its tertiary structure has also been recently resolved by X-ray analysis . This article describes the sub-cellular localization, phosphorylation and variations of NMNAT during the asexual life cycle of the parasite.
Synthesis and evaluation of polyclonal anti-His-PfNMNAT antibodies
IgG antibodies were obtained using the previously standardized protocol , in which 50 μg of recombinant protein previously obtained in another job  was used to perform 4 inoculations in 6-week-old BALB-C mice. Blood collection was performed every 8 days after inoculations. Antibodies were purified using affinity chromatography . To obtain IgY, 19-week old chickens (Babcock Brown) were inoculated 4 times with 150 μg of the recombinant protein . Eggs and blood were collected from day 0 to 1 month after the last inoculation. Antibodies were purified from egg yolk by thiophilic resin chromatography. For the evaluation of antibodies, different concentrations of recombinant His-PfNMNAT (3–125 ng) were separated by SDS-PAGE, electroblotted onto a PVDF membrane and developed with HRP. As a primary antibody, the sera used were obtained from avian (blood and egg yolk) and murine models at a dilution of 1:5000. As a control, 125 ng of BSA was used.
Plasmodium falciparum culture
FCR-3 strains of P. falciparum were cultured in vitro . The parasites were synchronized with 5% sorbitol at 37 °C for 10 min . Synchronic cultures in the ring stage were maintained in culture until reaching the trophozoite and schizont stages. Parasites at different asexual stages were obtained by centrifugation at 4000×g for 5 min, and erythrocytes were lysed with 0.01% saponin in PBS buffer at 4 °C for 15 min. The parasites were recovered by centrifugation at 17,000×g for 15 min, and then they were washed with 1× PBS until complete removal of the erythrocyte membrane and haemoglobin residues.
Collection of the cytoplasmic protein extracts
Approximately 2–4 million parasites were resuspended in 100 μl of Tris–magnesium gelatin (TMG) buffer (10 mM Tris–HCl, pH = 7.5, 1.5 mM MgCl2, 10 mM B-mercaptoethanol, and 10% glycerol) and protease inhibitor (Sigma, P8340; 1 mM AEBSF, 14 μM E64, 15 μM pepstatin A, 40 μM bestatin, 20 μM leupeptin, and 0.8 μM aprotinin). The extracts were then lysed by incubation with 0.2% NP-40 at 4 °C for 30 min and sonicated for 30 s with 50% amplitude. Cell debris was removed by centrifugation at 17,000×g for 30 min at 4 °C.
Immunodetection of PfNMNAT
Approximately 80–100 μg of soluble protein extract was separated on 12% SDS-PAGE gels and transferred to PVDF membranes (Thermo) for 2 h at 200 mA in electrotransfer buffer (Tris base 25 mM, 192 mM glycine and 10% V/V methanol, pH 8.3). The membranes were blocked in TBST-milk (TBST-L) for 12 h and incubated for another 12 h with the previously obtained sera (IgY or IgG) at a dilution of 1:1000 in TBST-L. Three washes were performed with TBST-L for 10 min each, before the samples were incubated for 2 h with the secondary antibody anti-mouse IgG or anti-chicken IgY coupled to biotin (1:8000) and 3 washes were made with TBST-L. The immunodetection reaction was developed with the chromogenic BCIP/NBT substrate system for streptavidin-conjugated alkaline phosphatase. The recombinant protein MBP-PfNMNAT was used as a positive control .
Immunofluorescence of PfNMNAT
To determine the subcellular localization of the endogenous protein by immunofluorescence, the protocol reported by Tokin et al.  was followed, and the pre-immune serum of the immunized chickens was used as the negative control. The plates were mounted with 10 μl of Fluoromount (Sigma) per slide, and the images were recorded with the Nikon C1 plus confocal fluorescence microscope using a 100× objective.
Identification of protein levels
To obtain parasites in a single stage, the culture was subjected to 3 synchronization cycles with sorbitol 5%, with pauses of 96 h (2 life cycles), between each synchronization. The parasites were obtained and lysed as mentioned above, we continued with the same immunodetection protocol where approximately 150 μg of protein was loaded for each of the stages. The antibodies used were those obtained from chicken blood. The recombinant protein MBP-PfNMNAT was used as a positive control .
Immunoprecipitation of PfNMNAT
Cytoplasmic protein extracts were prepared as described above using 1 mM Na3VO4. The extract was clarified for 1 h at 4 °C with constant stirring using 100 μl of thiophilic resin (Pierce) previously equilibrated with TMG buffer. The clear extract was incubated overnight with 50 μl of purified anti-His-PfNMNAT IgY antibody from chicken serum at 4 °C with constant stirring. 100 μl of thiophilic resin previously equilibrated with TMG buffer was added, and the sample was incubated for 2 rs at 4 °C with constant stirring. The immunoprecipitate was obtained by centrifuging the samples at 4500×g for 3 min at 4 °C. The precipitate obtained was washed 3 times with 500 μl of TMG buffer for 10 min in each case. The final pellet was resuspended in 80 μl of loading buffer for SDS-PAGE and incubated in boiling water for 6 min. The samples obtained were analysed by silver-stained SDS-PAGE. At the same time, Western blotting was performed with anti-His-PfNMNAT antibodies and antibodies to identify phosphorylations at the S, Y and T residues (Sigma).
Development of an immunological tool for PfNMNAT identification
PfNMNAT is identified in the soluble extracts of the parasite
PfNMNAT is a phosphorylation target
PfNMNAT is located in the cytoplasm of the parasite
PfNMNAT expression varies during the asexual life cycle
The results suggest that the regulation of PfNMNAT expression may be occurring at the post-transcriptional level, as has been shown for the parasite in recent studies [34, 35], because the overall analysis of transcripts for Plasmodium revealed that NMNAT does not have significant variations in the asexual life cycle . The parasite genome does not code for specialized transcription factors, whereas there are many genes coding for binding proteins and RNA regulation, indicating a possible regulation at levels subsequent to transcription [37–39].
PfNMNAT was immunodetected using different antibodies, observing a higher molecular weight band than expected, which could be attributed to post-translational modification. The cytoplasmic intracellular localization of the NMNAT protein in P. falciparum parasites was proven in the three stages of the asexual life cycle. PfNMNAT was observed at the transcriptional and protein levels. Protein levels showed variations during the asexual life cycle, with one major expression peak in the ring stage. The results of this work suggest that PfNMNAT is being regulated at post-transcription levels.
LS was in charge of obtaining and evaluating the antibodies under the supervision of GD and MR. DS performed the preliminary assays for localization of the protein under the supervision of MR. CN performed the final localization assays, protein levels in the stages and phosphorylation assays under the supervision of MR. All authors read and approved the final manuscript.
The authors thank COLCIENCIAS for funding Project 110156935240, the National University of Colombia, and the Faculty of Sciences. The authors thank the Laboratory of Molecular Parasitology at El Bosque University for their training in laboratory culture techniques.
The authors declare that they have no competing interests.
Availability of data and materials
Consent for publication
Ethics approval and consent to participate
The creation of antibodies has the ethical endorsement of the Facultad de Ciencias of the National University of Colombia, Sede Bogota.
This project was financed by Colciencias under the project 110156935240 and the National University of Colombia.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO. World malaria report. Geneva: World Health Organization; 2016.Google Scholar
- WHO. Estrategia Técnica Mundial Contra La Malaria 2016–2030. Organización Mundial de la Salud; 2015.Google Scholar
- Müller S. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol. 2004;53:1291–305.View ArticlePubMedGoogle Scholar
- Eren D. Plasmodium falciparum enzymes involved in redox balancing of nicotinimide nucleotides. Ph.D. dissertation, Drexel University College of Medicine, USA; 2003. p. 186.Google Scholar
- Zerez CR, Roth EF, Schulman S, Tanaka KR. Increased nicotinamide adenine dinucleotide content and synthesis in Plasmodium falciparum-infected human erythrocytes. Blood. 1990;75:1705–10.PubMedGoogle Scholar
- Lau C. The NMN/NaMN adenylyltransferase (NMNAT) protein family. Front Biosci. 2009;14:410–31.View ArticleGoogle Scholar
- Schweiger M, Hennig K, Lerner F, Niere M, Hirsch-Kauffmann M, Specht T, et al. Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis. FEBS Lett. 2001;492:95–100.View ArticlePubMedGoogle Scholar
- Stancek M, Schnell R, Rydén-Aulin M. Analysis of Escherichia coli nicotinate mononucleotide adenylyltransferase mutants in vivo and in vitro. BMC Biochem. 2005;6:16.View ArticlePubMedPubMed CentralGoogle Scholar
- Berger F, Lau C, Dahlmann M, Ziegler M. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem. 2005;280:36334–41.View ArticlePubMedGoogle Scholar
- Lau C, Dölle C, Gossmann TI, Agledal L, Niere M, Ziegler M. Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases. J Biol Chem. 2010;285:18868–76.View ArticlePubMedPubMed CentralGoogle Scholar
- Marín C. Identificación, expresión y caracterización de la nicotinamida/nicotinato mononucleótido adenililtransferasa de Plasmodium falciparum (PfNMNAT). Bogota: Universidad Nacional de Colombia; 2010. p. 117.Google Scholar
- O’Hara JK, Kerwin LJ, Cobbold SA, Tai J, Bedell TA, Reider PJ, et al. Targeting NAD+ metabolism in the human malaria parasite Plasmodium falciparum. PLoS ONE. 2014;9:e94061.View ArticlePubMedPubMed CentralGoogle Scholar
- Bathke J, Fritz-Wolf K, Brandstädter C, Burkhardt A, Jortzik E, Rahlfs S, et al. Structural and functional characterization of Plasmodium falciparum nicotinic acid mononucleotide adenylyltransferase. J Mol Biol. 2016;428:4946–61.View ArticlePubMedGoogle Scholar
- Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring: Cold Spring Harbor Laboratory Press; 1988. p. 726.Google Scholar
- Fang L. Antibody purification from Western blotting. Bio protocol. 2012;2:e133.Google Scholar
- Lomonte B. (2007) Manual de Métodos Inmunológicos. Universidad de Costa Rica, 138 pp. http://www.icp.ucr.ac.cr/~blomonte/. Accessed 28 Mar 2018.
- Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673–5.View ArticlePubMedGoogle Scholar
- Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum stages in culture. J Parasitol. 1979;65:418–20.View ArticlePubMedGoogle Scholar
- Nieto CA, Forero N, Ramírez MH. Design and production of various fusion proteins of the nicotinamide/nicotinate mononucleotide adenilil transferase (NMNAT) of Plasmodium falciparum. Rev Colomb Química. 2017;46:5–10.View ArticleGoogle Scholar
- Tonkin CJ, Van Dooren GG, Spurck TP, Struck NS, Good RT, Handman E, et al. Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. Mol Biochem Parasitol. 2004;137:13–21.View ArticlePubMedGoogle Scholar
- Berger F, Lau C, Ziegler M. Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1. Proc Natl Acad Sci USA. 2007;104:3765–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Sánchez-Lancheros DM, Ospina-Giraldo LF, Ramírez-Hernández MH. Nicotinamide mononucleotide adenylyltransferase of Trypanosoma cruzi (TcNMNAT): a cytosol protein target for serine kinases. Mem Inst Oswaldo Cruz. 2016;111:670–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol. 1999;294:1351–62.View ArticlePubMedGoogle Scholar
- Pease BN, Huttlin EL, Jedrychowski MP, Talevich E, Harmon J, Dillman T, et al. Global analysis of protein expression and phosphorylation of three stages of Plasmodium falciparum intraerythrocytic development. J Proteome Res. 2013;12:4028–45.View ArticlePubMedPubMed CentralGoogle Scholar
- Sasaki Y, Araki T, Milbrandt J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci. 2006;26:8484–91.View ArticlePubMedGoogle Scholar
- Kato M, Lin SJ. YCL047C/POF1 is a novel nicotinamide mononucleotide adenylyltransferase (NMNAT) in Saccharomyces cerevisiae. J Biol Chem. 2014;289:15577–87.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhai RG, Cao Y, Hiesinger PR, Zhou Y, Mehta SQ, Schulze KL, et al. Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity. PLoS Biol. 2006;4:2336–48.View ArticleGoogle Scholar
- Roth F, Raventos-suarez C, Nagel RL, Annenberg P. Glutathione stability and oxidative stress in P. falciparum infection in vitro: responses of normal and G6PD deficient cells. Biochem Biophys Res Commun. 1982;109:355–62.View ArticlePubMedGoogle Scholar
- Berger F, Ramírez-Hernández MH, Ziegler M. The new life of a centenarian: signalling functions of NAD(P). Trends Biochem Sci. 2004;29:111–8.View ArticlePubMedGoogle Scholar
- Palmieri F, Rieder B, Ventrella A, Blanco E, Do PT, Nunes-Nesi A, et al. Molecular identification and functional characterization of Arabidopsis thaliana mitochondrial and chloroplastic NAD+ carrier proteins. J Biol Chem. 2009;284:31249–59.View ArticlePubMedPubMed CentralGoogle Scholar
- Todisco S, Agrimi G, Castegna A, Palmieri F. Identification of the mitochondrial NAD+ transporter in Saccharomyces cerevisiae. J Biol Chem. 2006;281:1524–31.View ArticlePubMedGoogle Scholar
- PlasmoDB. http://plasmodb.org/plasmo/app/record/gene/PF3D7_1327600. Accessed 28 Mar 2018.
- Caro F, Ahyong V, Betegon M, DeRisi JL. Genome-wide regulatory dynamics of translation in the Plasmodium falciparum asexual blood stages. Elife. 2014;3:e04106.View ArticlePubMed CentralGoogle Scholar
- Doerig C, Rayner JC, Scherf A, Tobin AB. Post-translational protein modifications in malaria parasites. Nat Rev Microbiol. 2015;13:160–72.View ArticlePubMedGoogle Scholar
- Cui L, Lindner S, Miao J. Translational regulation during stage transitions in malaria parasites. Ann NY Acad Sci. 2015;1342:1–9.View ArticlePubMedGoogle Scholar
- López-Barragán MJ, Lemieux J, Quiñones M, Williamson KC, Molina-Cruz A, Cui K, et al. Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum. BMC Genomics. 2011;12:587.View ArticlePubMedPubMed CentralGoogle Scholar
- Coulson R, Hall N, Ouzounis C. Comparative genomics of transcriptional control in the human malaria parasite Plasmodium falciparum. Genome Res. 2004;14:1548–54.View ArticlePubMedPubMed CentralGoogle Scholar
- Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002;419:498–511.View ArticlePubMedGoogle Scholar
- Reddy BPN, Shrestha S, Hart KJ, Liang X, Kemirembe K, Cui L, et al. A bioinformatic survey of RNA-binding proteins in Plasmodium. BMC Genomics. 2015;16:890.View ArticlePubMedPubMed CentralGoogle Scholar